Abstract
Chronic oral administration of acyclovir or bromovinyl deoxyuridine to rabbits did not prevent recurrence of virus shedding or clinical corneal disease, nor did it alter the clinical course of recurrences of ocular herpetic disease or result in the appearance of resistant virus in tears.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Field H. J. Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy. Antimicrob Agents Chemother. 1982 May;21(5):744–752. doi: 10.1128/aac.21.5.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KAUFMAN H. E., HEIDELBERGER C. THERAPEUTIC ANTIVIRAL ACTION OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE IN HERPES SIMPLEX KERATITIS. Science. 1964 Aug 7;145(3632):585–586. doi: 10.1126/science.145.3632.585. [DOI] [PubMed] [Google Scholar]
- Kaufman H. E., Centifanto-Fitzgerald Y. M., Varnell E. D. Herpes simplex keratitis. Ophthalmology. 1983 Jun;90(6):700–706. doi: 10.1016/s0161-6420(83)34518-8. [DOI] [PubMed] [Google Scholar]
- Kaufman H. E., Meyer R. F., Laibson P. R., Waltman S. R., Nesburn A. B., Shuster J. J. Human leukocyte interferon for the prevention of recurrences of herpetic keratitis. J Infect Dis. 1976 Jun;133 (Suppl):A165–A168. doi: 10.1093/infdis/133.supplement_2.a165. [DOI] [PubMed] [Google Scholar]
- Nesburn A. B., Willey D. E., Trousdale M. D. Effect of intensive acyclovir therapy during artificial reactivation of latent herpes simplex virus. Proc Soc Exp Biol Med. 1983 Mar;172(3):316–323. doi: 10.3181/00379727-172-41563. [DOI] [PubMed] [Google Scholar]
- Nilsen A. E., Aasen T., Halsos A. M., Kinge B. R., Tjøtta E. A., Wikström K., Fiddian A. P. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982 Sep 11;2(8298):571–573. doi: 10.1016/s0140-6736(82)90658-4. [DOI] [PubMed] [Google Scholar]
- Shuster J. J., Kaufman H. E., Nesburn A. B. Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am J Ophthalmol. 1981 Mar;91(3):328–331. doi: 10.1016/0002-9394(81)90285-3. [DOI] [PubMed] [Google Scholar]
- Wellings P. C., Awdry P. N., Bors F. H., Jones B. R., Brown D. C., Kaufman H. E. Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol. 1972 Jun;73(6):932–942. doi: 10.1016/0002-9394(72)90463-1. [DOI] [PubMed] [Google Scholar]
- de Clercq E., Zhang Z. X., Sim I. S. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice. Antimicrob Agents Chemother. 1982 Sep;22(3):421–425. doi: 10.1128/aac.22.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
